Evidence map›Paper›PMID 39526044›Full record

ArticleFrontiers in cellular neuroscience2024

Editorial: Novel approaches to targeting the vasculature and metabolome to prevent brain aging and related diseases.

Jennifer Ihuoma, Sharon Negri, Amanda Morato Do Canto, Anika M S Hartz, Aditi Deshpande, Stefano Tarantini

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jennifer IhuomaCenter for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Sharon NegriCenter for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Amanda Morato Do CantoFaculty of Medical Sciences, State University of Campinas, Campinas, Brazil.
Anika M S HartzSanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, KY, United States.
Aditi DeshpandeBioAge Labs, Richmond, CA, United States.
Stefano TarantiniCenter for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.

Funding

Blood-Brain Barrier Repair in Alzheimer’s Disease with EpilepsyR01AG075583 · NIA · UNIVERSITY OF KENTUCKY · PI Bjoern Bauer, Anika M.S. Hartz · 2022 to 2026
$3.6M
Bisphenol-Induced Blood-Brain Barrier Dysfunction in Alzheimer’s DiseaseR01NS133250 · NINDS · UNIVERSITY OF KENTUCKY · PI Anika M.S. Hartz · 2023 to 2026
$2.9M
NIA NIH HHS R01 AG075583NINDS NIH HHS R01 NS133250
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

agingblood brain barrierbrain homeostasiscognitive declineneurodegenerative diseaseneurometabolic alterationsneurovascular uncouplingneurovascular unit

Identifiers

PMID39526044
PMCPMC11544536

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.